InvestorsHub Logo
Followers 8
Posts 443
Boards Moderated 0
Alias Born 03/25/2016

Re: None

Tuesday, 02/26/2019 8:08:48 AM

Tuesday, February 26, 2019 8:08:48 AM

Post# of 232909
What's done is done. Moving forward, the BODs must resolve to agree on a coherent strategy which addresses those shareholders who want to sell the company and those who want to develop it. I have no idea whether the majority of shareholders favor one or the other, but it seems from comments on the Board, that most would favor a leadership change and/or new role for NP. IMHO, as probably its largest shareholder, CMO, and Vice Chairman, RP is in the best position to address the changes which are needed. Leronlimab is an incredible product and story. I think the chapters to come will be exciting and rewarding.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News